Sex Differences in Long-Term Outcomes in Patients With Chronic Coronary Syndrome After Percutaneous Coronary

Naoyuki Akashi1, Tetsuya Matoba2, Takahide Kohro3

  • 1Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center.

Insights

This study found no significant sex differences in major adverse cardiovascular events (MACE) for patients with chronic coronary syndrome (CCS) after percutaneous coronary intervention (PCI). Long-term outcomes were similar for men and women following the procedure.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Sex differences in coronary artery disease (CAD) outcomes are reported but inconsistent for chronic coronary syndrome (CCS).
  • Previous studies show varied long-term outcomes for men and women with CCS.
  • This research addresses the need for clarity on sex-based long-term results after PCI in CCS patients.

Purpose of the Study:

  • To investigate potential sex differences in long-term outcomes.
  • To analyze major adverse cardiovascular events (MACE) in male versus female CCS patients post-PCI.
  • To provide evidence-based insights into sex-specific prognoses after coronary intervention.

Main Methods:

  • Retrospective, multicenter cohort study design.
  • Inclusion of 5,555 CCS patients undergoing percutaneous coronary intervention (PCI) from April 2013 to March 2019.
  • Primary outcome defined as MACE (cardiovascular death, myocardial infarction, or heart failure hospitalization), with a median follow-up of 917 days.

Main Results:

  • The overall incidence of MACE did not differ significantly between men and women.
  • Multivariable Cox regression analyses across four models confirmed no statistically significant sex-based disparities in MACE.
  • Hazard ratio for MACE was 1.20 (95% CI 0.97-1.47), with a log-rank P-value of 0.087.

Conclusions:

  • No significant sex differences were observed in MACE for patients with CCS undergoing PCI.
  • Long-term cardiovascular outcomes appear comparable between men and women with CCS post-intervention.
  • Findings suggest a similar prognosis for both sexes in this patient cohort.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
23
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
51
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
32
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
22